[go: up one dir, main page]

MX2020004118A - Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas. - Google Patents

Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas.

Info

Publication number
MX2020004118A
MX2020004118A MX2020004118A MX2020004118A MX2020004118A MX 2020004118 A MX2020004118 A MX 2020004118A MX 2020004118 A MX2020004118 A MX 2020004118A MX 2020004118 A MX2020004118 A MX 2020004118A MX 2020004118 A MX2020004118 A MX 2020004118A
Authority
MX
Mexico
Prior art keywords
diseases
liberibacter
compositions
treating
methods
Prior art date
Application number
MX2020004118A
Other languages
English (en)
Inventor
Hailing Jin
Chien Yu Huang
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of MX2020004118A publication Critical patent/MX2020004118A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8281—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for bacterial resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Virology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La descripción proporciona péptidos antimicrobianos estables (por ejemplo, antibacterianos o antifúngicos o ambos) (SAMPs) que se pueden usar en los métodos para prevenir o tratar una enfermedad bacteriana (por ejemplo, una enfermedad de Liberibacter, tal como enfermedad de amarillamiento de cítricos (también llamada Huanglongbing (HLB)) o enfermedad de Papa Manchada, y otras enfermedades bacterianas tal como aquellas provocadas por Agrobacterium tumefaciens (también conocido como Rhizobium radiobacter) y Pseudomonas syringae) en las plantas (por ejemplo, plantas de cítricos o plantas de papa). Los SAMPs descritos en la presente pueden ser estables en calor, así como estables en extractos de plantas y/o en lisados de plantas (por ejemplo, lisados de cítricos).
MX2020004118A 2017-10-23 2018-10-23 Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas. MX2020004118A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762575993P 2017-10-23 2017-10-23
US201862677817P 2018-05-30 2018-05-30
PCT/US2018/057153 WO2019084040A1 (en) 2017-10-23 2018-10-23 COMPOSITIONS AND METHODS FOR TREATING DISEASES INDUCED BY LIBERIBACTER AND OTHER BACTERIAL DISEASES

Publications (1)

Publication Number Publication Date
MX2020004118A true MX2020004118A (es) 2020-07-29

Family

ID=66247003

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2020004118A MX2020004118A (es) 2017-10-23 2018-10-23 Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas.
MX2024012722A MX2024012722A (es) 2017-10-23 2020-07-13 Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2024012722A MX2024012722A (es) 2017-10-23 2020-07-13 Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas

Country Status (7)

Country Link
US (2) US11963533B2 (es)
EP (1) EP3700547A4 (es)
CN (1) CN111246875B (es)
BR (1) BR112020007108A2 (es)
MX (2) MX2020004118A (es)
SG (1) SG11202003539VA (es)
WO (1) WO2019084040A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240109941A1 (en) * 2019-10-11 2024-04-04 The Regents Of The University Of California Compositions and methods for treating liberibacter diseases and other bacterial diseases
US11518694B2 (en) * 2019-12-18 2022-12-06 Maxwell Zachary Price Methods of inhibiting cyanobacteria using citron
CN111748555A (zh) * 2020-07-22 2020-10-09 西南大学 一种改良柑橘的sgRNA及其应用和使用方法
CA3210767A1 (en) * 2021-02-09 2022-08-18 The Regents Of The University Of California Immune regulators involved in defense against plant diseases caused by liberibacter species
CN114350702A (zh) * 2022-01-27 2022-04-15 浙江农林大学 一种柑橘的病毒接种方法
CN116715733A (zh) * 2022-10-18 2023-09-08 深圳润康生态环境股份有限公司 一种有效抑制柑橘黄龙病病原菌增殖的抗菌肽stj-2及其应用
CN118666972A (zh) * 2023-03-14 2024-09-20 中国科学院微生物研究所 一类抗菌肽及其在防治柑橘黄龙病中的应用
WO2024229347A1 (en) 2023-05-03 2024-11-07 Flagship Pioneering Innovations Vii, Llc Artificial tombusviridae satellite rnas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014009113A (es) * 2012-01-27 2014-11-10 Texas A & M Univ Sys Composiciones citricas resistentes a patogeno, organismos, sistemas y metodos.
MX373109B (es) * 2013-04-24 2020-03-25 Centro De Investig Y De Estudios Avanzados Del I P N Métodos para obtener plantas genéticamente modificadas resistentes a bacterias fitopatógenas que crecen en sus tejidos vasculares.
WO2017011815A2 (en) * 2015-07-15 2017-01-19 Texas A&M University Citrus plants resistant to citrus huanglongbing (ex greening) caused by candidatus liberibacter asiaticus (las) and bacterial canker caused by (xanthomonas axonopodis pv. citri) (xac) using spinach defensin genes in ctv vectors
CN108026541A (zh) * 2015-07-15 2018-05-11 德克萨斯A&M大学系统 抗病菌的柑橘属植物组合物、生物体、系统和方法
CN106337059A (zh) * 2016-09-12 2017-01-18 西南大学 一种改良柑桔黄龙病抗性的方法

Also Published As

Publication number Publication date
BR112020007108A2 (pt) 2020-10-13
WO2019084040A1 (en) 2019-05-02
US20240306649A1 (en) 2024-09-19
CN111246875A (zh) 2020-06-05
MX2024012722A (es) 2024-11-08
SG11202003539VA (en) 2020-05-28
EP3700547A4 (en) 2021-10-27
CN111246875B (zh) 2024-01-30
US20210186028A1 (en) 2021-06-24
US11963533B2 (en) 2024-04-23
EP3700547A1 (en) 2020-09-02

Similar Documents

Publication Publication Date Title
MX2020004118A (es) Composiciones y metodos para tratar enfermedades de liberibacter y otras enfermedades bacterianas.
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MX2021000077A (es) Composiciones que comprenden cepas bacterianas.
MX2018006398A (es) Composiciones que comprenden cepas bacterianas.
MX2018006239A (es) Composiciones que comprenden cepas bacterianas.
MX2018006399A (es) Composiciones que comprenden cepas bacterianas.
MX2017016529A (es) Composiciones que comprenden cepas bacterianas.
MX2017016564A (es) Composiciones que comprenden cepas bacterianas.
MX2017016560A (es) Composiciones que comprenden cepas bacterianas.
MX2017016525A (es) Composiciones que comprenden cepas bacterianas.
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2020003760A (es) Formulaciones de niraparib.
MX2020003421A (es) Metodos para la administracion de ciertos inhibidores del transportador vesicular de monoamina 2 (vmat2).
MX2020003770A (es) Terapias de combinacion para tratar cancer.
GB2541571A (en) Pharmaceutical compositions
SG10201902326XA (en) Mk2 inhibitors and uses thereof
WO2018136617A3 (en) Bacteria for treating cancer
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
MX2020003581A (es) Compuestos monobactamicos cromanos para el tratamiento de infecciones bacterianas.
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
MX2020003483A (es) Composiciones de pienso para animales mejoradas y metodos de uso.
MX2020006191A (es) Bacteriocinas terapeuticas.
MX2020009736A (es) Composiciones que comprenden cepas bacterianas.
MX2020004424A (es) Formulacion aerosolizable.